IPO registrations (S-1, F-1) · Registrants
Flyte Aviation, Inc.
- SEC CIK
- 1716621 · filings on EDGAR ↗
- Name on the registration
- Catheter Precision, Inc.
- Former names
- Catheter Precision, Inc. (2023–2026); Ra Medical Systems, Inc. (2017–2023)
- Registration
- Form S-1, first filed 2018-07-16, last 2026-07-06; 7 initial registrations, 13 amendments
- Outcome
- Final prospectus filed 2018-09-27; declared effective 2018-09-26
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 1670 HIGHWAY 160 WEST, SUITE 205, Fort Mill, SC 29708
- EIN
- 38-3661826
- Ticker
- VJET (NYSE)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Flyte Aviation, Inc. on the corporate pages
On this site
- Business registration: RA MEDICAL SYSTEMS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: RA MEDICAL SYSTEMS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: RA MEDICAL SYSTEMS, INC EXACT (EIN (EXACT))
- Form D issuer: Ra Medical Systems, Inc. EXACT (CIK (EXACT))
- SEC filer: Catheter Precision, Inc. EXACT (CIK (EXACT))
- Person page: Richard Mejia Jr Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 45
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2018-07-16 | S-1 | S-1 (registration) | Ra Medical Systems, Inc. | 0001193125-18-218840 ↗ |
| 2018-08-24 | S-1/A | S-1/A (amendment) | Ra Medical Systems, Inc. | 0001193125-18-257795 ↗ |
| 2018-09-17 | S-1/A | S-1/A (amendment) | Ra Medical Systems, Inc. | 0001193125-18-274611 ↗ |
| 2018-09-24 | S-1/A | S-1/A (amendment) | Ra Medical Systems, Inc. | 0001193125-18-281010 ↗ |
| 2018-09-26 | S-1MEF | S-1MEF (added securities) | Ra Medical Systems, Inc. | 0001193125-18-284361 ↗ |
| 2018-09-26 | EFFECT | EFFECT (declared effective) | Ra Medical Systems, Inc. | 9999999995-18-002462 ↗ |
| 2018-09-27 | 424B4 | 424B4 (final prospectus) | Ra Medical Systems, Inc. | 0001193125-18-285681 ↗ |
| 2020-04-16 | S-1 | S-1 (registration) | Ra Medical Systems, Inc. | 0001564590-20-016928 ↗ |
| 2020-05-15 | S-1/A | S-1/A (amendment) | Ra Medical Systems, Inc. | 0001564590-20-025657 ↗ |
| 2020-05-20 | S-1/A | S-1/A (amendment) | Ra Medical Systems, Inc. | 0001564590-20-026227 ↗ |
| 2020-05-20 | EFFECT | EFFECT (declared effective) | Ra Medical Systems, Inc. | 9999999995-20-001217 ↗ |
| 2020-05-21 | 424B4 | 424B4 (final prospectus) | Ra Medical Systems, Inc. | 0001564590-20-026560 ↗ |
| 2020-07-16 | S-1 | S-1 (registration) | Ra Medical Systems, Inc. | 0001564590-20-032490 ↗ |
| 2020-07-27 | S-1/A | S-1/A (amendment) | Ra Medical Systems, Inc. | 0001564590-20-033454 ↗ |
| 2020-07-30 | S-1MEF | S-1MEF (added securities) | Ra Medical Systems, Inc. | 0001564590-20-034579 ↗ |
| 2020-07-30 | EFFECT | EFFECT (declared effective) | Ra Medical Systems, Inc. | 9999999995-20-001975 ↗ |
| 2020-08-03 | 424B4 | 424B4 (final prospectus) | Ra Medical Systems, Inc. | 0001564590-20-035368 ↗ |
| 2021-02-04 | EFFECT | EFFECT (declared effective) | Ra Medical Systems, Inc. | 9999999995-21-000459 ↗ |
| 2022-01-14 | S-1 | S-1 (registration) | Ra Medical Systems, Inc. | 0001564590-22-001389 ↗ |
| 2022-01-26 | S-1/A | S-1/A (amendment) | Ra Medical Systems, Inc. | 0001193125-22-017594 ↗ |
| 2022-01-31 | S-1/A | S-1/A (amendment) | Ra Medical Systems, Inc. | 0001193125-22-021989 ↗ |
| 2022-02-03 | S-1/A | S-1/A (amendment) | Ra Medical Systems, Inc. | 0001193125-22-026151 ↗ |
| 2022-02-03 | EFFECT | EFFECT (declared effective) | Ra Medical Systems, Inc. | 9999999995-22-000329 ↗ |
| 2022-02-07 | 424B1 | 424B1 (final prospectus) | Ra Medical Systems, Inc. | 0001193125-22-028753 ↗ |
| 2022-07-13 | EFFECT | EFFECT (declared effective) | Ra Medical Systems, Inc. | 9999999995-22-002053 ↗ |
| 2022-09-23 | EFFECT | EFFECT (declared effective) | Ra Medical Systems, Inc. | 9999999995-22-002816 ↗ |
| 2023-02-08 | EFFECT | EFFECT (declared effective) | Ra Medical Systems, Inc. | 9999999995-23-000328 ↗ |
| 2023-04-12 | EFFECT | EFFECT (declared effective) | Ra Medical Systems, Inc. | 9999999995-23-000908 ↗ |
| 2023-05-09 | EFFECT | EFFECT (declared effective) | Ra Medical Systems, Inc. | 9999999995-23-001348 ↗ |
| 2023-12-28 | EFFECT | EFFECT (declared effective) | Catheter Precision, Inc. | 9999999995-23-003775 ↗ |
| 2023-12-28 | EFFECT | EFFECT (declared effective) | Catheter Precision, Inc. | 9999999995-23-003777 ↗ |
| 2024-06-04 | S-1 | S-1 (registration) | Catheter Precision, Inc. | 0001654954-24-007285 ↗ |
| 2024-06-14 | S-1/A | S-1/A (amendment) | Catheter Precision, Inc. | 0001654954-24-007750 ↗ |
| 2024-06-26 | S-1/A | S-1/A (amendment) | Catheter Precision, Inc. | 0001654954-24-008205 ↗ |
| 2024-08-27 | S-1/A | S-1/A (amendment) | Catheter Precision, Inc. | 0001654954-24-011104 ↗ |
| 2024-08-29 | EFFECT | EFFECT (declared effective) | Catheter Precision, Inc. | 9999999995-24-002679 ↗ |
| 2024-08-30 | S-1MEF | S-1MEF (added securities) | Catheter Precision, Inc. | 0001654954-24-011293 ↗ |
| 2024-09-03 | 424B1 | 424B1 (final prospectus) | Catheter Precision, Inc. | 0001654954-24-011367 ↗ |
| 2024-11-21 | S-1 | S-1 (registration) | Catheter Precision, Inc. | 0001654954-24-014768 ↗ |
| 2024-12-04 | EFFECT | EFFECT (declared effective) | Catheter Precision, Inc. | 9999999995-24-003663 ↗ |
| 2025-01-22 | EFFECT | EFFECT (declared effective) | Catheter Precision, Inc. | 9999999995-25-000160 ↗ |
| 2025-05-30 | EFFECT | EFFECT (declared effective) | Catheter Precision, Inc. | 9999999995-25-001802 ↗ |
| 2026-06-22 | S-1 | S-1 (registration) | Catheter Precision, Inc. | 0001437749-26-021318 ↗ |
| 2026-07-06 | S-1/A | S-1/A (amendment) | Catheter Precision, Inc. | 0001437749-26-022592 ↗ |
| 2026-07-10 | EFFECT | EFFECT (declared effective) | Catheter Precision, Inc. | 9999999995-26-002252 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BUCHBINDER MAURICE | Director | 3 | 2018–2019 | ||
| Burstein Martin | TenPercentOwner | 4 | 2018–2019 | ||
| Burstein Melissa | Director,Officer,TenPercentOwner; TenPercentOwner | Executive Vice President | 2 | 2018–2020 | |
| COLOMBATTO MARTIN J | Director | 12 | 2018–2026 | ||
| Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 | TenPercentOwner | 6 | 2018–2020 | ||
| ENQUIST WILLIAM R | Director | 9 | 2018–2021 | ||
| Irwin Dean | Director,Officer,TenPercentOwner; TenPercentOwner | See Remarks | 7 | 2018–2020 | |
| Jackson Andrew C. | Officer | CFO; CFO & Interim CEO; CFO & Secretary | 11 | 2018–2022 | |
| Kraws Jeffrey J | Officer | Co-President | 8 | 2018–2020 | |
| Martin Burstein Living Trust Dated January 28, 2002 | TenPercentOwner | 4 | 2018–2019 | ||
| Mejia Richard Jr | Director | 9 | 2018–2021 | person page Fuzzy | |
| Saad Mark E | Director | 6 | 2018–2021 | ||
| Horwood Daniel | Officer | General Counsel | 8 | 2018–2020 | |
| FOGARTY THOMAS G | Officer | See Remarks | 2 | 2018–2019 | |
| McGuire Jonathan Will | Director,Officer | CEO & Secretary; Chief Executive Officer | 10 | 2020–2023 | |
| Stafslien Joan | Director | 5 | 2020–2021 | ||
| Meline Susanne | Director | 4 | 2021–2023 | ||
| Conn Brian | Officer | Chief Financial Officer | 1 | 2022 | |
| Caruso James Joseph | Director | 8 | 2023–2026 | ||
| JENKINS DAVID A | Director,Officer; Officer | Chairman of the Board and CEO; Ex. Chairman of the Board; Exec. Chairman of the Board; Executive Chairman and CEO; Executive Chairman of Board | 12 | 2023–2026 | |
| Passey Steven K | Officer | Chief Financial Officer | 1 | 2023 | |
| Thomassen Margrit | Officer | Interim CFO and Secretary | 2 | 2024 | |
| Francis, John P. | Director | 2 | 2024 | ||
| Jacques Marie-Claude | Officer | Chief Commercial Officer | 3 | 2024–2025 | |
| Jenkins Family Charitable Institute | TenPercentOwner | 1 | 2024 | ||
| Arno Andrew | Director | 4 | 2024–2026 | ||
| ANDERSON PHILIP J | Officer | Chief Financial Officer | 3 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-04-06 | Ra Medical Systems, Inc. | Biotechnology | $7,999,798 | $7,999,798 | 1 | 1 |
| 2022-08-04 | Ra Medical Systems, Inc. | Biotechnology | $6,216,700 | $6,216,700 | 14 | 1 |
| 2018-07-10 | Ra Medical Systems, Inc. | Biotechnology | $5,340,000 | $5,340,000 | 64 | 1 |
| 2018-06-18 | Ra Medical Systems, Inc. | Biotechnology | $60,193,059 | $60,193,059 | 7 | 1 |
| 2017-09-20 | Ra Medical Systems, Inc. | Biotechnology | $19,000,000 | $18,282,000 | 49 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.